CHICAGO (EGMN) - Patients with gastric cancer have better outcomes if they are given adjuvant capecitabine plus oxaliplatin after undergoing curative resection that includes an extended lymph-node dissection, according to results of the CLASSIC trial from China, South Korea, and TaiwanInvestigators randomized 1,035 patients to either simple observation or XELOX (the combination of capecitabine plus oxaliplatin) after...